Nkarta’s AML Update Disappoints, But New Conditioning Regimen Might Improve Response

 
• By Joseph Haas
Natural killer cells
Nkarta reported mixed data for its NK cell therapy in AML • Source: Shutterstock

More from Clinical Trials

More from R&D